Literature DB >> 18956393

Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent.

Ji-Ae Park1, Jae-Jun Lee, Jae-Chang Jung, Dae-Yeul Yu, Chilhwan Oh, Seunghan Ha, Tae-Jeong Kim, Yongmin Chang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18956393     DOI: 10.1002/cbic.200800529

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  15 in total

1.  Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent.

Authors:  Young-Seung Kim; Yang Zhou; Henry Bryant; Diane E Milenic; Kwamena E Baidoo; Bobbi K Lewis; Joseph A Frank; Martin W Brechbiel
Journal:  Bioorg Med Chem Lett       Date:  2015-04-04       Impact factor: 2.823

Review 2.  Nanotechnology and its use in imaging and drug delivery (Review).

Authors:  Serjay Sim; Nyet Kui Wong
Journal:  Biomed Rep       Date:  2021-03-05

3.  Gadolinium Complex of (125)I/(127)I-RGD-DOTA Conjugate as a Tumor-Targeting SPECT/MR Bimodal Imaging Probe.

Authors:  Ji-Ae Park; Jung Young Kim; Yong Jin Lee; Wonho Lee; Sang Moo Lim; Tae-Jeong Kim; Jeongsoo Yoo; Yongmin Chang; Kyeong Min Kim
Journal:  ACS Med Chem Lett       Date:  2012-12-17       Impact factor: 4.345

4.  Comparison of the equilibrium, kinetic and water exchange properties of some metal ion-DOTA and DOTA-bis(amide) complexes.

Authors:  Gyula Tircsó; Enikő Tircsóné Benyó; Zoltán Garda; Jaspal Singh; Robert Trokowski; Ernő Brücher; A Dean Sherry; Éva Tóth; Zoltán Kovács
Journal:  J Inorg Biochem       Date:  2020-02-20       Impact factor: 4.155

5.  Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging.

Authors:  Sashiprabha M Vithanarachchi; Matthew J Allen
Journal:  Curr Mol Imaging       Date:  2012-10-01

Review 6.  Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Authors:  Zhuxian Zhou; Zheng-Rong Lu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-10-09

7.  cRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).

Authors:  Lalit N Goswami; Lixin Ma; Quanyu Cai; Saurav J Sarma; Satish S Jalisatgi; M Frederick Hawthorne
Journal:  Inorg Chem       Date:  2013-02-07       Impact factor: 5.165

8.  Integrin Targeted MR Imaging.

Authors:  Mingqian Tan; Zheng-Rong Lu
Journal:  Theranostics       Date:  2011-01-19       Impact factor: 11.556

Review 9.  The functions and applications of RGD in tumor therapy and tissue engineering.

Authors:  Fen Wang; Yuanyuan Li; Yingqiang Shen; Anming Wang; Shuling Wang; Tian Xie
Journal:  Int J Mol Sci       Date:  2013-06-27       Impact factor: 5.923

10.  Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates.

Authors:  Stavros Melemenidis; Andrew Jefferson; Neil Ruparelia; Asim M Akhtar; Jin Xie; Danny Allen; Alastair Hamilton; James R Larkin; Francisco Perez-Balderas; Sean C Smart; Ruth J Muschel; Xiaoyuan Chen; Nicola R Sibson; Robin P Choudhury
Journal:  Theranostics       Date:  2015-02-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.